About ADME-Toxicology Testing
ADME-toxicology testing is the evaluation of the metabolism of a drug molecule and its toxicity in an organism. ADME describes the pharmacological changes of a drug
inside a living organism. These studies are traditionally carried out in vivo or in vitro in a controlled laboratory environment.
Technavio's analysts forecast the global ADME-toxicology testing market to grow at a CAGR of 10.65% over the period 2014-2019.
Covered in this Report
This report covers the present scenario and the growth prospects of the global ADME-toxicology testing market for the period 2015-2019. To calculate the market size,
Technavio analysts consider revenue generated from the sales of products (instruments, assays systems, software solutions, and reagents) used in the following ADME-
toxicology testing technologies:
In vivo: test performed inside a living organism for drug evaluation
In vitro: test performed in a laboratory (outside of a living cell)
This report provides the details about the market in the following there regions: Americas, APAC and EMEA.
Key Regions
• Americas
• APAC
• EMEA
Key Vendors
• Accelrys (Dassault Systemes)
• Agilent Technologies
• Bio-Rad Laboratories
• Promega
• Sigma Aldrich
• Thermo Fisher Scientific
Other Prominent Vendor
• Cyprtorex
• CytoPulse
• Entelos
• LI-COR Biosciences
• Mattek
• Miltenyi Biotec
• Molecular Toxicology
• Quintiles
• RTI Health Solutions
• SBW
• Xenobiotic Detection Systems
• Xenometrix
Market Driver
• Demand from Biotechnology and Pharmaceutical Companies
• For a full, detailed list, view our report
Market Challenge
• High Cost
• For a full, detailed list, view our report
Market Trend
• Advances in Technology
• For a full, detailed list, view our report
Key Questions Answered in this Report
• What will the market size be in 2019 and what will the growth rate be?
• What are the key market trends?
• What is driving this market?
• What are the challenges to market growth?
• Who are the key vendors in this market space?
• What are the market opportunities and threats faced by the key vendors?
• What are the strengths and weaknesses of the key vendors?
01. Executive Summary
02. List of Abbreviations
03. Scope of the Report
03.1 Market Overview
03.2 Product Offerings
04. Market Research Methodology
04.1 Market Research Process
04.2 Research Methodology
05. Introduction
06. Market Landscape
06.1 Market Overview
06.2 Market Size and Forecast
06.3 Five Forces Analysis
07. ADME-Toxicology Testing
08. Market Segmentation by Technology
09. Global In vivo Technology Market
09.1 Market Overview
09.1.1 Market Size and Forecast
10. Global In vitro Technology Market
10.1 Market Overview
10.1.1 Market Size and Forecast
11. Geographical Segmentation
11.1 ADME-Toxicology Testing Market in Americas
11.1.1 Market size and forecast
11.2 ADME-Toxicology Testing Market in EMEA
11.2.1 Market size and forecast
11.3 ADME-Toxicology Testing Market in APAC
11.3.1 Market size and forecast
12. Buying Criteria
13. Market Growth Drivers
14. Drivers and their Impact
15. Market Challenges
16. Impact of Drivers and Challenges
17. Market Trends
18. Trends and their Impact
19. Vendor Landscape
19.1 Competitive Scenario
19.1.1 Key News
19.1.2 Mergers and Acquisitions
19.2 Market Share Analysis 2014
19.2.1 Accelrys (Acquired by Dassault Systemes)
19.2.2 Agilent Technologies
19.2.3 Bio-Rad Laboratories
19.2.4 Promega
19.2.5 Sigma-Aldrich
19.2.6 Thermo Fisher Scientific
19.3 Other Prominent Vendors
20. Key Vendor Analysis
20.1 Dassault Systemes
20.1.1 Key Facts
20.1.2 Business Overview
20.1.3 Product Segmentation
20.1.4 Geographical Segmentation by Revenue 2013
20.1.5 Business Strategy
20.1.6 Recent Developments
20.1.7 SWOT Analysis
20.2 Agilent Technologies
20.2.1 Key Facts
20.2.2 Business Overview
20.2.3 Business Segmentation by Revenue 2013
20.2.4 Business Segmentation by Revenue 2012 and 2013
20.2.5 Geographical Segmentation by Revenue 2013
20.2.6 Business Strategy
20.2.7 Recent Developments
20.2.8 SWOT Analysis
20.3 Bio-Rad Laboratories Inc.
20.3.1 Key Facts
20.3.2 Business Description
20.3.3 Business Segmentation
20.3.4 Business Strategy
20.3.5 Revenue by Business Segmentation
20.3.6 Revenue Comparison 2011 and 2012
20.3.7 Revenue by Geographical Segmentation
20.3.8 Key Information
20.3.9 SWOT Analysis
20.4 Promega
20.4.1 Key Facts
20.4.2 Business Overview
20.4.3 Products and Services
20.4.4 Recent Developments
20.4.5 SWOT Analysis
20.5 Sigma-Aldrich
20.5.1 Key Facts
20.5.2 Business Overview
20.5.3 Business Segmentation
20.5.4 Business Strategy
20.5.5 Business Segmentation by Revenue
20.5.6 Sales by Geography
20.5.7 Key Developments
20.5.8 SWOT Analysis
20.6 Thermo Fisher Scientific
20.6.1 Key Facts
20.6.2 Business Overview
20.6.3 Business Segmentation by Revenue 2014
20.6.4 Business Segmentation by Revenue 2013 and 2014
20.6.5 Geographical Segmentation by Revenue 2014
20.6.6 Business Strategy
20.6.7 Recent Developments
20.6.8 SWOT Analysis
21. Other Reports in this Series
List of Exhibits
Exhibit 1: Market Research Methodology
Exhibit 2: Global ADME-Toxicology Testing Market 2014-2019 ($ millions)
Exhibit 3: Various Pharmacological Activities of a Drug Inside the Body
Exhibit 4: ADMETox Properties
Exhibit 5: Segmentation of Global ADME-Toxicology Testing Market by Technology
Exhibit 6: Segmentation of Global ADME-Toxicology Testing Market by Technology in 2014
Exhibit 7: Global In Vivo Technology Market 2014-2019 ($ millions)
Exhibit 8: Global In Vitro Technology Market 2014-2019 ($ millions)
Exhibit 9: Segmentation of Global ADME-Toxicology Testing Market by Technology 2014-2019 ($ million)
Exhibit 10: Segmentation of Global ADME-Toxicology Testing Market by Technology 2014-2019
Exhibit 11: Segmentation of Global ADME-Toxicology Testing Market by Geography 2014-2019
Exhibit 12: ADME-Toxicology Testing in Americas 2014-2019 ($ million)
Exhibit 13: ADME-Toxicology Testing in EMEA 2014-2019 ($ million)
Exhibit 14: ADME-Toxicology Testing in APAC 2014-2019 ($ million)
Exhibit 15: Segmentation of Global ADME-Toxicology Testing Market by Geography 2014-2019 in ($ millions)
Exhibit 16: Segmentation of Global ADME-Toxicology Testing Market by Geography 2014-2019
Exhibit 17: Dassault Systemes Key Take-aways
Exhibit 18: Agilent Technologies Key Take-aways
Exhibit 19: Bio-Rad Laboratories Key Take-aways
Exhibit 20: Promega Key Take-aways
Exhibit 21: Sigma-Aldrich Key Take-away
Exhibit 22: Thermo Fisher Scientific Key Take-aways
Exhibit 23: Dassault Systemes: Product Segmentation 2013
Exhibit 24: Dassault Systemes: Geographical Segmentation by Revenue 2013
Exhibit 25: Agilent Technologies: Business Segmentation by Revenue 2013
Exhibit 26: Agilent Technologies: Business Segmentation by Revenue 2012 and 2013 (US$ billion)
Exhibit 27: Agilent Technologies: Geographical Segmentation by Revenue 2013
Exhibit 28: Bio-Rad Laboratories Inc.: Business Segmentation
Exhibit 29: Bio-Rad Laboratories Inc.: Revenue by Business Segmentation 2012
Exhibit 30: Bio-Rad Laboratories Inc.: Revenue Comparison by Business Segmentation 2011 and 2012 (US$ million)
Exhibit 31: Bio-Rad Laboratories Inc.: Revenue by Geographical Segmentation 2012
Exhibit 32: Promega: Key Products and Services
Exhibit 33: Sigma-Aldrich: Business Segmentation
Exhibit 34: Sigma-Aldrich: Business Segmentation by Revenue 2013
Exhibit 35: Sigma-Aldrich: Geographical Segmentation by Revenue 2013
Exhibit 36: Thermo Fisher Scientific: Business Segmentation by Revenue 2014
Exhibit 37: Thermo Fisher Scientific: Business Segmentation by Revenue 2013 and 2014 ($ billion)
Exhibit 38: Thermo Fisher Scientific: Geographical Segmentation by Revenue 2014
